You are probably correct coppa1 although I hope we pessimists are wrong.
As posted, Cellmid will likely remain busy and productive while others are not. That is the key invest.ent case as I see it.
I would also like to see the supression of proteins and genes associated with the lung inflammation pathways of COVID-19 patients ageing explored scientifically.
You are probably correct coppa1 although I hope we pessimists...
-
- There are more pages in this discussion • 449 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable